RobertSSmyth-MedinaMD

Ophthalmology • Mission Hills, CA

Physician

Join to view full profile

Dr. Smyth-Medina is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Smyth-Medina's full profile

Already have an account?

Office
11550 Indian Hills Rd
Suite 341
Mission Hills, CA 91345
Phone+1 818-365-0606

Fax+1 818-898-0205

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 1991 - 1994
Maimonides Medical CenterInternship, Transitional Year, 1989 - 1990
Autonomous Metropolitan University XochimilcoClass of 1987

Certifications & Licensure

CA State Medical License 1990 - 2026
American Board of Ophthalmology Ophthalmology

Clinical Trials

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation Start of enrollment: 2014 May 01
Completed
Phase 3
A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease Start of enrollment: 2021 Jan 11
Completed
Phase 2

Publications & Presentations

PubMed

Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial.
Barry A Schechter, Maitee Urbieta, Jason Bacharach, Melissa Toyos, Robert Smyth-Medina
Clinical Ophthalmology. 2022-01-01
5 citations
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.
David Wirta, Michael S Korenfeld, Shane Foster, Robert Smyth-Medina, Jason Bacharach
Clinical Ophthalmology. 2021-10-08
9 citations
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.
Jason Bacharach, David Wirta, Robert Smyth-Medina, Michael S Korenfeld, Shane R Kannarr
Clinical Ophthalmology. 2021-06-25

Journal Articles

Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration with Visual Field in Acquired Ptosis
Charles B Slonim, Michael S Korenfeld, Robert Smyth-Medina, David L Wirta, JAMA Ophthalmology